close
Share with your friends

Subscribe to KPMG's Newsletter "KPMG Asset Management – Tax Update"

Kameralinse

The new edition of our quarterly newsletter on transactions in the global life sciences industry, glances back at the significant deals that took place in Q1 2021.

  • Sustained tailwind in biotech and medical devices & diagnostics subsectors drove life sciences M&A activity in Q1 2021. 
  • With one blockbuster deal but also by robust growth across all subsectors, deal value exceeded prior-year quarter.

Register here:

Connect with us

Stay up to date with what matters to you

Gain access to personalized content based on your interests by signing up today

Sign up today